Diagnostic development and its link to pharma

J. Villacian (Janssen Pharmaceutica)

Source: Value-Dx event 2019: VALUE-Dx kick off meeting and course

Number: 6

Disease area: -

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
J. Villacian (Janssen Pharmaceutica). Diagnostic development and its link to pharma. Value-Dx event 2019: VALUE-Dx kick off meeting and course

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.

Related content which might interest you:

Clinical use of new and repurposed drugs: the role and contribution of the ERS collaborative projects Source: International Congress 2017 – In the frontline of the fight against tuberculosis Year: 2017
Keynote: Diagnostic and the therapeutic applications of bronchoscopy Source: Virtual Congress 2020 – Paediatric procedures Year: 2020
Facts and perspectives in the development of new diagnostics Source: Annual Congress 2008 - New insights into tuberculosis control Year: 2008
Basic science and diagnosis Source: School Course 2013 - Cystic Fibrosis Year: 2013
The Innovative Medicines Initiative (IMI): a new opportunity for scientific collaboration between academia and industry at the European level Source: Eur Respir J 2008; 31: 924-926 Year: 2008
Biomedical research by industry Source: ERS Summit on priorities in respiratory medicine 2011 Year: 2011
Diagnostic challenges in IPF Source: ERS webinars 2019 - Diagnostic challenges in IPF Year: 2019
New technologies in bronchoscopy: which are still research tools and which are ready for clinical use? Source: Annual Congress 2010 - PG13 Core Curriculum Postgraduate Course: Interventional pulmonology Year: 2010
Respiratory and pancreatic syndrome: Diagnostic and practical management Source: Annual Congress 2010 - Congenital lesions and rare pathology Year: 2010
Precision medicine in tuberculosis treatment – a role for pharmacogenetics? Source: International Congress 2018 – Challenges in tuberculosis care Year: 2018
eTRIKS IT platfroms for large-scale biomedical research Source: International Congress 2015 – Non-exhaled biomarkers in the assessment of airways disease Year: 2015
Genomics and system biology: where does it take us in the future? Source: Annual Congress 2011 - PG3 Workshop: Genomics and proteomics of lung disease Year: 2011
Digital health to end tuberculosis in the Sustainable Development Goals era: achievements, evidence and future perspectives Source: Eur Respir J, 50 (5) 1701632; 10.1183/13993003.01632-2017 Year: 2017